Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 846 blog entries.

January 2026

Hidden Biases in AI-Powered Pathology: How Data Center Signatures Undermine Cancer Detection Models

2026-01-26T11:50:20+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  The combination of digital pathology with artificial intelligence (AI) shows promise in improving cancer diagnosis by enhancing analysis of histopathology images. However, recent studies revealed concerning biases in these systems that could impact their reliability in clinical settings.  In a new study, researchers from Ontario Tech University, Brock University, and Wilfrid Laurier University in Canada identified factors that contribute to the ability of deep learning models designed [...]

Hidden Biases in AI-Powered Pathology: How Data Center Signatures Undermine Cancer Detection Models2026-01-26T11:50:20+00:00

NYU Langone Health Propels Disease Detection into the Digital Age

2026-01-28T11:05:37+00:00

Digital Pathology Program Promises Faster Diagnoses & Improved Patient Outcomes NYU Langone Health has launched a digital pathology program, transforming disease diagnosis from microscopes to high-definition images, shareable in real time across the hospital network. This change offers unprecedented clarity for viewing human tissue samples, shorter diagnosis time, and enhanced collaboration within a field that [...]

NYU Langone Health Propels Disease Detection into the Digital Age2026-01-28T11:05:37+00:00

Diagnostic Digital Pathology Shaping the Future of Medicine

2026-01-28T14:04:17+00:00

Driven by pathologists, optimized for AP, and designed to seamlessly integrate with your existing and future IT infrastructure, our HALO AP and HALO AP Dx diagnostic digital pathology platforms are shaping the future of medicine. Whether your lab is looking to integrate advanced AI and image analysis solutions or needs a cutting-edge FDA-cleared platform, our latest [...]

Diagnostic Digital Pathology Shaping the Future of Medicine2026-01-28T14:04:17+00:00

Comparison of Digital Displays for Efficient Diagnosis and Accuracy

2026-01-28T09:14:12+00:00

he following abstract is drawn from a recently published paper in Journal of Pathology Informatics. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Monika Lamba Sainia,d, Amanda Hemmerichb,d, Anna Banach-Ovensb, [...]

Comparison of Digital Displays for Efficient Diagnosis and Accuracy2026-01-28T09:14:12+00:00

The Digital Pathology Illusion: Why Are We Building Storage Instead of Solutions?

2026-01-27T16:58:13+00:00

by Rajendra Singh MD Professor of Pathology, University of Pennsylvania Co-Founder, PathPresenter Digital pathology has finally moved from “nice-to-have” to a global strategic priority. The benefits are real and include remote sign-out, operational efficiency, collaboration, education, and the promise of AI. But as health systems rush to digitize, many are falling for a [...]

The Digital Pathology Illusion: Why Are We Building Storage Instead of Solutions?2026-01-27T16:58:13+00:00

Illumina Obtains CMS Reimbursement for TruSight Oncology Comprehensive Test

2026-01-27T15:22:43+00:00

The US Centers for Medicare and Medicaid Services has granted Illumina reimbursement for its TruSight Oncology Comprehensive assay, the company said on Tuesday. The US Food and Drug Administration-approved comprehensive genomic profiling test will be reimbursed at a rate of $2,989.55 per test using Proprietary Laboratory Analysis code 0543U, effective Jan. 1, 2026. The test interrogates [...]

Illumina Obtains CMS Reimbursement for TruSight Oncology Comprehensive Test2026-01-27T15:22:43+00:00

Fujifilm and Voicebrook Partner to Deliver Voice-Enabled Reporting within the Synapse Pathology Ecosystem

2026-01-27T15:22:36+00:00

FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic imaging and enterprise imaging solutions, today announced a strategic partnership with Voicebrook, Inc., a leader in pathology reporting solutions, to integrate Voicebrook’s VoiceOver PRO reporting platform with Fujifilm’s Synapse® Pathology, a comprehensive pathology PACS that streamlines case management through proprietary advances in image digitization. This collaboration brings together comprehensive [...]

Fujifilm and Voicebrook Partner to Deliver Voice-Enabled Reporting within the Synapse Pathology Ecosystem2026-01-27T15:22:36+00:00

Applications and Challenges of Utilizing Digital Pathology and AI-enabled Workflows in Clinical Trials

2026-01-27T11:46:44+00:00

The following abstract is drawn from a recently published paper in Journal of Pathology Informatics. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Manu Sebastiana, Harsh Batrab, Monika Lamba [...]

Applications and Challenges of Utilizing Digital Pathology and AI-enabled Workflows in Clinical Trials2026-01-27T11:46:44+00:00

Image Analysis Enhances Pathology Evaluation of Preclinical Studies, not Replaces it

2026-01-26T11:44:21+00:00

In this episode of the Digital Pathology Podcast, I sit down with Danielle Brown, the General Manager at Charles River Laboratories and an expert in toxicologic pathology. Danielle and I explore the evolving role of image analysis in preclinical studies, diving into how this technology enhances—rather than replaces—the expertise of pathologists. We discuss the [...]

Image Analysis Enhances Pathology Evaluation of Preclinical Studies, not Replaces it2026-01-26T11:44:21+00:00

Success Story: Accelerating Clinical Trials for Oncology with Imagenomix Predict and PathPresenter ConsultConnect

2026-01-23T10:32:16+00:00

Zero-footprint web portals and AI-enhanced workflows reduce screening bottlenecks for an AKT-Pathway clinical trial In Brief Oncology research trials require patients but enrollment can be a major limiter. 40% of oncology trials fail due to under-enrollment and 80% do not meet enrollment timelines Imagenomix addresses the enrollment challenge: Imagenomix’s Predict AI model for rapid mutation prediction from [...]

Success Story: Accelerating Clinical Trials for Oncology with Imagenomix Predict and PathPresenter ConsultConnect2026-01-23T10:32:16+00:00
Go to Top